Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,805 | 182 | 99.9% |
| Education | $2.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,114 | 86 | $0 (2024) |
| Relievant Medsystems, Inc. | $309.41 | 3 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $202.01 | 17 | $0 (2019) |
| Daiichi Sankyo Inc. | $150.26 | 18 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $142.24 | 5 | $0 (2021) |
| Egalet US Inc | $112.11 | 6 | $0 (2017) |
| BioDelivery Sciences International, Inc. | $111.81 | 7 | $0 (2021) |
| PFIZER INC. | $102.66 | 7 | $0 (2021) |
| Medtronic USA, Inc. | $90.08 | 5 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $81.68 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.80 | 4 | Abbott Laboratories ($351.08) |
| 2023 | $275.74 | 6 | Abbott Laboratories ($254.73) |
| 2022 | $944.25 | 23 | Abbott Laboratories ($605.74) |
| 2021 | $429.61 | 7 | Abbott Laboratories ($338.28) |
| 2020 | $77.60 | 5 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($60.50) |
| 2019 | $576.84 | 20 | Abbott Laboratories ($325.79) |
| 2018 | $837.85 | 51 | Abbott Laboratories ($538.48) |
| 2017 | $1,282 | 67 | Abbott Laboratories ($682.56) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/01/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $98.65 | General |
| Category: Neuromodulation | ||||||
| 08/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $135.26 | General |
| Category: Neuromodulation | ||||||
| 04/09/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $117.17 | General |
| Category: Neuromodulation | ||||||
| 07/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Neuromodulation | ||||||
| 07/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Drug Infusion Systems | ||||||
| 04/19/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Neuromodulation | ||||||
| 02/23/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Neuromodulation | ||||||
| 02/14/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $138.54 | General |
| Category: Neuromodulation | ||||||
| 01/18/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Neuromodulation | ||||||
| 12/29/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Neuromodulation | ||||||
| 12/23/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $83.58 | General |
| Category: Neuromodulation | ||||||
| 12/23/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Neuromodulation | ||||||
| 12/13/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $136.85 | General |
| Category: Pain | ||||||
| 11/07/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Neuromodulation | ||||||
| 10/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Neuromodulation | ||||||
| 09/20/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: PRIMARY CARE | ||||||
| 09/12/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Neuromodulation | ||||||
| 09/12/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neuromodulation | ||||||
| 08/30/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neuromodulation | ||||||
| 08/23/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $144.37 | General |
| Category: Pain | ||||||
| 08/08/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Neuromodulation | ||||||
| 08/02/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Neuromodulation | ||||||
| 08/02/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 74 | 89 | $39,500 | $9,119 |
| 2022 | 16 | 586 | 1,185 | $305,189 | $66,232 |
| 2021 | 13 | 406 | 1,026 | $702,126 | $78,769 |
| 2020 | 9 | 345 | 667 | $779,400 | $61,025 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 16 | $12,000 | $3,872 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 22 | $8,349 | $2,312 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,862 | $1,654 | 24.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 16 | 20 | $12,000 | $1,218 | 10.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 17 | $289.00 | $62.40 | 21.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 64 | 82 | $64,000 | $19,978 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 207 | $77,782 | $16,583 | 21.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 39 | 49 | $29,400 | $9,564 | 32.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 85 | 135 | $81,000 | $8,169 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $21,625 | $5,327 | 24.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 11 | 16 | $8,419 | $3,082 | 36.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2022 | 17 | 27 | $4,086 | $1,004 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $5,186 | $1,002 | 19.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 12 | $5,879 | $660.26 | 11.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $4,839 | $543.06 | 11.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 28 | 144 | $1,440 | $132.02 | 9.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 28 | 33 | $561.00 | $112.41 | 20.0% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2022 | 32 | 58 | $116.00 | $36.58 | 31.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 192 | $576.00 | $18.53 | 3.2% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2022 | 32 | 130 | $260.00 | $15.72 | 6.0% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2022 | 18 | 20 | $20.00 | $5.12 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 517 | $258,500 | $50,027 | 19.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $25,200 | $5,066 | 20.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 39 | 41 | $61,500 | $4,692 | 7.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 18 | 18 | $58,500 | $4,445 | 7.6% |
About Dr. Rizwan Khan, DO
Dr. Rizwan Khan, DO is a Anesthesiology healthcare provider based in Waco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346390671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Khan, DO has received a total of $4,808 in payments from pharmaceutical and medical device companies, with $383.80 received in 2024. These payments were reported across 183 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,805).
As a Medicare-enrolled provider, Khan has provided services to 1,411 Medicare beneficiaries, totaling 2,967 services with total Medicare billing of $215,145. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Waco, TX
- Active Since 01/11/2007
- Last Updated 08/22/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1346390671
Products in Payments
- OCTRODE (Device) $652.24
- PROCLAIM (Device) $559.31
- Proclaim Family of SCS IPGs (Device) $468.22
- Octrode SCS Leads (Device) $344.20
- Proclaim IPG (Device) $338.28
- Intracept (Device) $309.41
- SCS IPGs (Device) $275.61
- DRG IPGs (Device) $228.69
- SCS leads (Device) $219.22
- XTAMPZA (Drug) $119.56
- BELBUCA (Drug) $111.81
- Movantik (Drug) $98.98
- ARYMO ER (Drug) $95.09
- RELISTOR ORAL (Drug) $81.68
- GENERAL - PAIN MANAGEMENT (Device) $75.00
- KYPHON Balloon Kyphoplasty (Device) $60.00
- Morphabond ER (Drug) $51.28
- LYRICA (Drug) $48.75
- HYSINGLA ER (Drug) $44.56
- Xtampza ER (Drug) $44.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Waco
Bennjamin Fronk, M.d, M.D
Anesthesiology — Payments: $11,356
Jose Soto, M.d, M.D
Anesthesiology — Payments: $1,975
Dr. Laurie Lazott, M.d, M.D
Anesthesiology — Payments: $1,720
Mandy Shah, M.d, M.D
Anesthesiology — Payments: $739.25
Rebecca Guess, M.d, M.D
Anesthesiology — Payments: $704.61
Jeffrey Manning, M.d, M.D
Anesthesiology — Payments: $687.59